Table 1.
Patient Characteristics
| Patient No./Sex/Age, y/Race | CLE Type | Old Medications | New Medications |
|---|---|---|---|
| 1/F/43/White | Generalized DLE | Hydroxychloroquine sulfate | Lenalidomide |
| 2/F/48/Black | Generalized DLE | Prednisone, hydroxychloroquine, quinacrine hydrochloride, azathioprine | Azathioprine |
| 4/F/42/White | Localized DLE | Hydroxychloroquine | Thalidomide, methotrexate |
| 6/F/48/White | SCLE | Chloroquine phosphate, quinacrine, hydroxychloroquine, prednisone | Methotrexate |
| 7/F/19/Asian | Generalized DLE/SLE | None | Prednisone, hydroxychloroquine, Quinacrine, cyclophosphamide |
| 8/F/83/Hispanic | SCLE | Hydroxychloroquine, prednisone | Methotrexate |
| 10/F/61/Black | Generalized DLE | Hydroxychloroquine, quinacrine, | Hydroxychloroquine |
| 11/F/50/Black | Localized DLE/SLE | Chloroquine, quinacrine, methylprednisolone, dapsone, methotrexate, cyclosporine, azathioprine | Lenalidomide |
Abbreviations: CLE, cutaneous lupus erythematosus; DLE, discoid lupus erythematosus; SCLE, subacute CLE; SLE, systemic lupus erythematosus.